Dr. Peter de Blank, MD
Claim this profileCincinnati Children's Hospital Medical Center
Expert in Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
20 reported clinical trials
29 drugs studied
Area of expertise
1Brain Tumor
Global LeaderStage IV
Stage I
Stage II
2Diffuse Intrinsic Pontine Glioma
NTRK positive
IDH positive
Stage IV
Affiliated Hospitals
Clinical Trials Peter de Blank, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
More about Peter de Blank, MD
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Peter de Blank, MD has experience with
- Radiation Therapy
- Selumetinib
- Temozolomide
- Cyclophosphamide
- Lomustine
- Vincristine
Breakdown of trials Peter de Blank, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Brain Cancer
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter de Blank, MD specialize in?
Peter de Blank, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are Stage I.
Is Peter de Blank, MD currently recruiting for clinical trials?
Yes, Peter de Blank, MD is currently recruiting for 11 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Peter de Blank, MD has studied deeply?
Yes, Peter de Blank, MD has studied treatments such as Radiation Therapy, Selumetinib, Temozolomide.
What is the best way to schedule an appointment with Peter de Blank, MD?
Apply for one of the trials that Peter de Blank, MD is conducting.
What is the office address of Peter de Blank, MD?
The office of Peter de Blank, MD is located at: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229 United States. This is the address for their practice at the Cincinnati Children's Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.